Wegovy price cuts: What next for our approach to weight-loss in Ireland?

Novo Nordisk has significantly lowered the cash price of Wegovy. What does this mean for users of the drug in Ireland, and will it have wider implications for the weight-loss drug is administered or treated in Ireland more broadly? Joining Shane Beatty to discuss is Dr Brendan O’Shea, Assistant Professor of Primary Care at Trinity College Dublin & Bernadette Keenan, Committee Member of the Irish Coalition for People Living with Obesity (ICPO).